Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
about
Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosisOptimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasPrinciples of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.The PRESTO technique for fMRI.Combined low-dose contrast-enhanced MR angiography and perfusion for acute ischemic stroke at 3T: A more efficient stroke protocol.Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T.Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging.DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma.Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke.Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
P2860
Q24649817-F063F3F0-7BB4-49AE-8A0E-AB297DE63490Q30419061-B1972E89-CF98-424A-825F-EE1E51242A11Q30818733-93ED001B-08EA-4423-97F4-E87E68256E91Q34127616-F4BC4BC1-EDF3-4C0B-BB45-FA747034C0BEQ34155336-B6265512-2345-4990-ACC0-90205BA05670Q34568305-AE44DC24-1208-41A4-94B8-04F4BF3E0EE3Q35886114-5E71CC5D-E428-4DFA-8373-F28395CEADDEQ37317806-9C558E54-F743-4588-A791-B0759775E313Q48113208-24D0DED9-DCEB-4313-9B06-232E2B361E08Q48217522-0A1A3991-58B8-4A73-8FC8-9AD774E4E939Q48834982-7F48BBA8-B6A1-4E69-866D-7AAB39835E24Q51495475-3742E895-80B6-4698-85A4-448B193E888C
P2860
Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@ast
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@en
type
label
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@ast
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@en
prefLabel
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@ast
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@en
P2093
P1433
P1476
Three-dimensional dynamic susc ...... ility and contrast agent dose.
@en
P2093
Christoph Manka
Hans H Schild
Juergen Gieseke
P304
P356
10.1148/RADIOL.2343040359
P407
P577
2005-01-21T00:00:00Z